Multiple myeloma trials in Malaysia

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

  Where

  Ampang, George Town, Johor Bharu, Kota Kinabalu, Kuching

  Age

  18 years and over

  People

  230 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07589634